We came across a bullish thesis on Moderna, Inc. (MRNA) on Substack by Natan. In this article, we will summarize the bulls’ ...

On November 30th, exactly 3 years ago, Moderna’s ($MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced ...

Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue pharmaceutical behemoth.

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...

CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: 7 th Annual Evercore ISI HealthCONx ...